These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 6826099)
1. Absorption of prednisolone in patients with Crohn's disease. Shaffer JA; Williams SE; Turnberg LA; Houston JB; Rowland M Gut; 1983 Mar; 24(3):182-6. PubMed ID: 6826099 [TBL] [Abstract][Full Text] [Related]
2. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease. Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153 [TBL] [Abstract][Full Text] [Related]
3. Non-absorption of enteric-coated prednisolone. Normal absorption of non-enteric-coated prednisolone in a patient with Crohn's disease and massive intestinal resection. Olivesi A Therapie; 1985; 40(1):5-7. PubMed ID: 4002184 [No Abstract] [Full Text] [Related]
4. Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration. Tanner AR; Halliday JW; Powell LW Digestion; 1981; 21(6):310-5. PubMed ID: 7250552 [TBL] [Abstract][Full Text] [Related]
6. Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent. Rodrigues CA; Nabi EM; Spiliadis C; McIntyre PB; Phongsathorn V; Lennard-Jones JE; Rosen A; Willoughby JM Aliment Pharmacol Ther; 1987 Oct; 1(5):391-9. PubMed ID: 2979682 [TBL] [Abstract][Full Text] [Related]
7. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Teahon K; Smethurst P; Levi AJ; Menzies IS; Bjarnason I Gut; 1992 Mar; 33(3):320-3. PubMed ID: 1568650 [TBL] [Abstract][Full Text] [Related]
8. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Azcue M; Rashid M; Griffiths A; Pencharz PB Gut; 1997 Aug; 41(2):203-8. PubMed ID: 9301499 [TBL] [Abstract][Full Text] [Related]
9. A comparison of budesonide with prednisolone for active Crohn's disease. Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530 [TBL] [Abstract][Full Text] [Related]
10. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study. Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692 [TBL] [Abstract][Full Text] [Related]
11. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500 [TBL] [Abstract][Full Text] [Related]
18. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine. Sandborn WJ; Tremaine WJ; Lawson GM Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141 [TBL] [Abstract][Full Text] [Related]
19. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. Den Hond E; Hiele M; Peeters M; Ghoos Y; Rutgeerts P JPEN J Parenter Enteral Nutr; 1999; 23(1):7-11. PubMed ID: 9888411 [TBL] [Abstract][Full Text] [Related]
20. Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid. Nishida T; Miwa H; Yamamoto M; Koga T; Yao T Gut; 1982 Sep; 23(9):751-7. PubMed ID: 7106622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]